COVID-19: understanding a workforce
PDF (Português (Portugal))

Keywords

occupational health; SARS-CoV-2; COVID-19; serological tests

How to Cite

Silva, R., Almeida, J., Martins, M. ., & Ferreira, M. (2023). COVID-19: understanding a workforce. Journal of Health Research & Innovation, 5(2), 35–45. https://doi.org/10.37914/riis.v5i2.233

Abstract

Background: the COVID-19 pandemic forced to extra occupational and individual measures in the industry. Objectives: to assess the incidence of SARS-CoV-2 and transmission chains, to control the spread of the disease and to assess the presence of anti- SARS-CoV-2 antibodies. Methodology: prospective longitudinal descriptive study (laboratory test) conducted after the appearance of a case of SARS-CoV-2 in a wood industry in the North of Portugal. A total of 873 workers participated in the study (mean age: 41.77 years, 50.4% men). Isolation and disinfection measures were implemented, as well as screening of the working population, and a combination of serological tests and RT-PCR. Results: the original case has an epidemiological link outside the industry. 31 workers (3.55%) had a positive result in serological tests, after, these employees were subjected to RT-PCR tests, which resulted in new cases. Subsequently, the 31 persons were re-tested with serological tests, 10 positive tests for IgM and 2 for IgG were founded. Conclusion: the serological test whose result was positive or negative, by itself, should not constitute evidence (exclusion) of infection. To limit the spread of the virus, it is crucial to ensure that the diagnosis is made with RT-PCR tests. The promising association between IgG and immunity needs further evidence. With the measures implemented, it was possible to control the spread of the disease and give permission to return working.

https://doi.org/10.37914/riis.v5i2.233
PDF (Português (Portugal))

References

Bastos, M., Tavaziva, G., Abidi, S., Campbell, J., Haraoui, L., Johnston, J., … Khan, F. (2020). Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. JMB, 370: m2516. https://doi.org/10.1136/bmj.m2516

Caruana, G., Croxatto, A., Coste, A., Oposta, O., Lamoth, F., Jaton, K. & Greub, G. (2020). Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results. Clinical Microbiology and Infection, 26, 1178-1182. https://doi.org/10.1016/j.cmi.2020.06.019

Cheng, V., Wong, S., Chuangc, V., Soa, S., Chena, J., Sridhar, S., … Yuend, K. (2020). The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2. Journal Infection, 2020, 81(1), 107-114. https://doi.org/10.1016/j.jinf.2020.04.024

Cirrincione, L., Plescia, F., Ledda, C., Rapisarda, V., Martorana, D., Moldovan E., … Cannizzaro, E. (2020). COVID-19 Pandemic: Prevention and Protection Measures to Be Adopted at the Workplace. Sustainability, 12 (3603), 18. https://doi.org/10.3390/su12093603

Conceição, C., Lopes, D., Ramos, J., Cristóvão, J., Vieira, M., Pingarilho, M., … Parreira, R. (2020). COVID-19: o que são, o que nos dizem, e quais as limitações dos métodos de diagnóstico de base não-molecular. Comissão de Saúde Ocupacional, Biossegurança e Qualidade (CoSOBQ) do Instituto de Higiene e Medicina Tropical/Universidade Nova de Lisboa. https://www.ihmt.unl.pt/covid-19-o-que-sao-o-que-nos-dizem-e-quais-as-limitacoes-dos-metodos-de-diagnostico-de-base-nao-molecular/.

Delgado, B., Mendes, I., Pereira, S. & Carneiro, L., (2021). Impacte da COVID-19 na atividade física e qualidade de vida de doentes em reabilitação cardíaca. Revista de Investigação & Inovação em Saúde, 4(2) 29-40. https://doi.org/10.37914/riis.v4i2.120

Direção-Geral da Saúde (DGS). (2020a). Orientação nº 015/2020 de 23/03/2020 – COVID-10: Diagnóstico Laboratorial. https://www.dgs.pt/directrizes-da-dgs/orientacoes-e-circulares-informativas/orientacao-n-0152020-de-23032020-pdf.aspx.

Direção-Geral da Saúde (DGS). (2020b). Circular Informativa Conjunta Nº 003/CD/100.20.200. Testes Laboratoriais para SARS-CoV-2; Testes rápidos. https://www.dgs.pt/directrizes-da-dgs/orientacoes-e-circulares-informativas/circular-informativa-conjunta-dgsinfarmedinsa-n-003cd10020200-de-27052020-pdf.aspx.

Direção-Geral da Saúde (DGS). (2020c). Orientação nº 006/2020 de 26/02/2020 – Infeção por SARS-CoV-2 (COVID 19): Procedimentos de prevenção, controlo e vigilância em empresas. https://www.dgs.pt/directrizes-da-dgs/orientacoes-e-circulares-informativas/orientacao-n-0062020-de-26022020-pdf.aspx.

European Center for Disease Prevention and Control (ECDC). (2020). COVID-19 clusters and outbreaks in occupational settings in the EU/EEA and UK, 11 August, 2020. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessment-coronavirus-disease-2019-eighth-update-8-april-2020.pdf.

Ghafari, A., Meurant, R. & Ardakani, A. (2020). COVID-19 Serological Tests: How Well Do They Actually Perform? Diagnostics, 10 (453), 1-14. https://doi.org/10.3390/diagnostics10070453

Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F., … Wang, J. (2020). Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clinical Infectious Diseases, 71, 778-785. https://doi.org/10.1093/cid/ciaa310

Hellewell, J., Abbott, S., Gimma, A., Bosse, N., Jarvis, C., Russell, T., … Edmunds, W. (2020). Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health, 8, e448-6. https://doi.org/10.1016/ S2214-109X(20)30074-7

https://doi.org/10.1016/S1473-3099(20)30273-5

Johns Hopkins Center for Health Security (2020). Serology testing for COVID-19. https://www.centerforhealthsecurity.org/resources/COVID-19/COVID-19-fact-sheets/200228-Serology-testing-COVID.pdf

Rana, W., Mukhtar, S. & Mukhtar, S. (2020). Mental health of medical workers in Pakistan during the pandemic COVID-19 outbreak. Asian Journal of Psychiatry, 51. https://doi.org/10.1016/j.ajp.2020.102080

Seow, J., Graham, C., Merrick, B., Acors, S., Steel, K., Hemmings, O., … Doores, K. (2020). Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. Nat Microbiol. 5(12), 1598–1607. https://doi:10.1038/s41564-020-00813-8

Tang, Y., Schmitz, J., Persing, D. & Stratton, C. (2020). Laboratory Diagnosis of COVID-19: Current Issues and Challenges. Journal of Clinical Microbiology, 58(6), e00512-20. https://doi.org/10.1128/JCM.00512-20

Theel, E., Slev, P., Wheeler, S., Couturier, M., Wong, S. & Kadkhoda, K. (2020). The Role of Antibody Testing for SARS-CoV-2: Is There One? Journal of Clinical Microbiology. 58 (8). e00797-20.https://doi.org/10.1128/JCM.00797-20

World Health Organization.WHO. (2020). Advice on the use of point-of-care immunodiagnostic tests for COVID-19: Scientific brief. https://www.who.int/docs/default-source/coronaviruse/sb-2020-1-poc-immunodiagnostics-2020-04-08-e.pdf?sfvrsn=4c26ac39_2

Yong, S., Anderson, D., Wei, W., Pang, J., Chia, W., Tan, C., … Lee, V. (2020). Connecting clusters of COVID-19: an epidemiological and serological investigation. Lancet Infect Dis, 20, 809–815.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Manuela Ferreira